KREBS BIOCHEMICALS & INDUSTRIES Share Price

Krebs Biochemicals & Industries Ltd is an India-based company, which is engaged in the business of manufacture of active pharmaceutical ingredients. The Company manufactures bulk active pharmaceutical ingredients, pharmaceutical intermediates, fine chemicals, nutraceuticals utilizing two revenue streams: contract manufacturing for large pharmaceutical and multinational companies, and development of its products for sale in global markets. Its products include Androstenedione, Lovastatin, and Simvastatin. The Company’s pilot or research and development stages products are Amlodipine, Cetirizine, Orlistat, Serratiopepetidase, Telmisartan, and Phenylephrine. The Company has two manufacturing facilities one at Regadichelaka, Nellore District and another one at Kothapalli Village, Kasimkota Mandal, Visakhapatnam District, Andhra Pradesh, India.As of 25 May 2026, KREBS BIOCHEMICALS & INDUSTRIES share price is ₹61.81. The stock opened at ₹61.75, compared to its previous close of ₹58.87. During today's trading session, KREBS BIOCHEMICALS & INDUSTRIES share price moved in the range of ₹60.01 to ₹61.81, with an average price of ₹60.91 for the day. Looking at its last 52-week, the stock has touched a low of ₹60.01 and a high of ₹61.81. On the performance front, KREBS BIOCHEMICALS & INDUSTRIES share price has declined by 10.12% over the last six months and is down 19.28% on a year-on-year basis.

The market capitalization of KREBS BIOCHEMICALS & INDUSTRIES is ₹122 Crs, with a P/E ratio of -7.2 and a dividend yield of 0.00%.